NPHC.OB: Summary for NUTRA PHARMA CORP - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 3:24am EST - Canadian Markets open in 6 hours and 6 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Nutra Pharma Corp. (NPHC.OB)

On Feb 9: 0.46 USD 0.00 (0.00%)

MORE ON NPHC.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

NUTRA PHARMA CORP (OTC BB:NPHC.OB) Delayed quote data

Last Trade:	0.46 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.46
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.02 - 0.07
Volume:	0
Avg Vol (3m):	60,437.5
Market Cap:	123.83M
P/E (ttm):	N/A
EPS (ttm):	-0.01
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add NPHC.OB to Portfolio

Download Data

HEADLINES

•	NUTRA PHARMA CORP Financials
	EDGAR Online Financials (Sat, Feb 6)

•	Nutra Pharma Announces Fourth Quarter Sales for Its Over-the-Counter (OTC) Pain Reliever, Cobroxin
	Business Wire (Tue, Feb 2)

•	NUTRA PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
	EDGAR Online (Tue, Feb 2)

•	NUTRA PHARMA CORP Files SEC form 10-Q/A, Quarterly Report
	EDGAR Online (Mon, Jan 25)

•	NUTRA PHARMA CORP Files SEC form 10-K/A, Annual Report
	EDGAR Online (Mon, Jan 25)

•	XenaCare Holdings Announces Expansion of National Advertising Campaign for its Over-the-Counter (OTC) Pain Reliever, Cobroxin, as Retailer Commitments
	Business Wire (Tue, Jan 19)

•	Nutra Pharma to Present and Exhibit at Upcoming Investment Conferences in Scottsdale, Arizona, and Orlando, Florida
	Business Wire (Thu, Jan 14)

•	NUTRA PHARMA CORP Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant
	EDGAR Online (Thu, Dec 31)

•	NUTRA PHARMA CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibit
	EDGAR Online (Thu, Dec 24)

•	Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx Over-the-Counter and Prescription Treatments for Chronic Pain
	Business Wire (Mon, Dec 7)

More Headlines for NPHC.OB...

BUSINESS SUMMARY

Nutra Pharma Corp., a development stage biopharmaceutical company, engages in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infec...

Full Company Profile

Add to Portfolio

Email to a Friend

•